1. LB1531A. Administration of abatacept, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial. (15th December 2022) Authors: Ko, Emily R; Anstrom, Kevin J; Lachiewicz, Anne; Panettieri, Reynold; Maillo, Martin; O'Halloran, Jane A; Boucher, Cynthia; Maldonado, Michael A; Chang, Soju; Bozzette, Samuel; Powderly, William G Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LB1531B. Administration of the TNF-alpha inhibitor, infliximab, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial. (15th December 2022) Authors: O'Halloran, Jane A; Anstrom, Kevin J; Kedar, Eyal; McCarthy, Matthew W; Ko, Emily R; Melsheimer, Richard; Boucher, Cynthia; Chang, Soju; Bozzette, Samuel; Powderly, William G Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗